HIGGINS ARTHUR J - 30 Jun 2026 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Reporting relationship: Director
Issuer ticker: ZBH
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:22:59 UTC
Prior SEC filing: 27 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Arthur J. Higgins (power of attorney previously filed)

Key filing fact

HIGGINS ARTHUR J filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 02 Jul 2026.

Key facts

This page summarizes HIGGINS ARTHUR J's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2026, 16:22.

Change

Previous filing in this sequence was filed on 27 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001142083 Primary reporting owner

HIGGINS ARTHUR J

Relationship: Director
Address: 345 E. MAIN STREET, WARSAW
Signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Arthur J. Higgins (power of attorney previously filed)
Signature date: 02 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZBH transaction Derivative

Phantom Stock Units

Award

Transaction value
Shares: +317
Change %: +0.85%
Price: $0.000000^*
Shares after: 37,675
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 317
Exercise price: $86.65
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Footnote F2

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Footnote F3

Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.